Biomarkers of Alzheimer's disease among Mexican Americans

Sid E. O'Bryant, Guanghua Xiao, Melissa Edwards, Michael Devous, Veer Bala Gupta, Ralph Martins, Fan Zhang, Robert Barber

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Mexican Americans are the fastest aging segment of the U.S. population, yet little scientific literature exists regarding the Alzheimer's disease (AD) among this segment of the population. The extant literature suggests that biomarkers of AD will vary according to race/ethnicity though no prior work has explicitly studied this possibility. The aim of this study was to create a serum-based biomarker profile of AD among Mexican American. Methods: Data were analyzed from 363 Mexican American participants (49 AD and 314 normal controls) enrolled in the Texas Alzheimer's Research & Care Consortium (TARCC). Non-fasting serum samples were analyzed using a luminex-based multi-plex platform. A biomarker profile was generated using random forest analyses. Results: The biomarker profile of AD among Mexican Americans was different from prior work from non-Hispanic populations with regards to the variable importance plots. In fact, many of the top markers were related to metabolic factors (e.g., FABP, GLP-1, CD40, pancreatic polypeptide, insulin-like-growth factor, and insulin). The biomarker profile was a significant classifier of AD status yielding an area under the receiver operating characteristic curve, sensitivity, and specificity of 0.77, 0.92, and 0.64, respectively. Combining biomarkers with clinical variables yielded a better balance of sensitivity and specificity. Conclusion: The biomarker profile for AD among Mexican American cases is significantly different from that previously identified among non-Hispanic cases from many large-scale studies. This is the first study to explicitly examine and provide support for blood-based biomarkers of AD among Mexican Americans. Areas for future research are highlighted.

Original languageEnglish (US)
Pages (from-to)841-849
Number of pages9
JournalJournal of Alzheimer's Disease
Volume34
Issue number4
DOIs
StatePublished - 2013

Fingerprint

Alzheimer Disease
Biomarkers
Population
Literature
Pancreatic Polypeptide
Sensitivity and Specificity
Glucagon-Like Peptide 1
Somatomedins
Serum
ROC Curve
Insulin
Research

Keywords

  • Alzheimer's disease
  • biomarkers
  • Mexican American
  • neuropsychology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

O'Bryant, S. E., Xiao, G., Edwards, M., Devous, M., Gupta, V. B., Martins, R., ... Barber, R. (2013). Biomarkers of Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease, 34(4), 841-849. https://doi.org/10.3233/JAD-122074

Biomarkers of Alzheimer's disease among Mexican Americans. / O'Bryant, Sid E.; Xiao, Guanghua; Edwards, Melissa; Devous, Michael; Gupta, Veer Bala; Martins, Ralph; Zhang, Fan; Barber, Robert.

In: Journal of Alzheimer's Disease, Vol. 34, No. 4, 2013, p. 841-849.

Research output: Contribution to journalArticle

O'Bryant, SE, Xiao, G, Edwards, M, Devous, M, Gupta, VB, Martins, R, Zhang, F & Barber, R 2013, 'Biomarkers of Alzheimer's disease among Mexican Americans', Journal of Alzheimer's Disease, vol. 34, no. 4, pp. 841-849. https://doi.org/10.3233/JAD-122074
O'Bryant, Sid E. ; Xiao, Guanghua ; Edwards, Melissa ; Devous, Michael ; Gupta, Veer Bala ; Martins, Ralph ; Zhang, Fan ; Barber, Robert. / Biomarkers of Alzheimer's disease among Mexican Americans. In: Journal of Alzheimer's Disease. 2013 ; Vol. 34, No. 4. pp. 841-849.
@article{18823b26bf6d49a4ab827a7093e03fe2,
title = "Biomarkers of Alzheimer's disease among Mexican Americans",
abstract = "Background: Mexican Americans are the fastest aging segment of the U.S. population, yet little scientific literature exists regarding the Alzheimer's disease (AD) among this segment of the population. The extant literature suggests that biomarkers of AD will vary according to race/ethnicity though no prior work has explicitly studied this possibility. The aim of this study was to create a serum-based biomarker profile of AD among Mexican American. Methods: Data were analyzed from 363 Mexican American participants (49 AD and 314 normal controls) enrolled in the Texas Alzheimer's Research & Care Consortium (TARCC). Non-fasting serum samples were analyzed using a luminex-based multi-plex platform. A biomarker profile was generated using random forest analyses. Results: The biomarker profile of AD among Mexican Americans was different from prior work from non-Hispanic populations with regards to the variable importance plots. In fact, many of the top markers were related to metabolic factors (e.g., FABP, GLP-1, CD40, pancreatic polypeptide, insulin-like-growth factor, and insulin). The biomarker profile was a significant classifier of AD status yielding an area under the receiver operating characteristic curve, sensitivity, and specificity of 0.77, 0.92, and 0.64, respectively. Combining biomarkers with clinical variables yielded a better balance of sensitivity and specificity. Conclusion: The biomarker profile for AD among Mexican American cases is significantly different from that previously identified among non-Hispanic cases from many large-scale studies. This is the first study to explicitly examine and provide support for blood-based biomarkers of AD among Mexican Americans. Areas for future research are highlighted.",
keywords = "Alzheimer's disease, biomarkers, Mexican American, neuropsychology",
author = "O'Bryant, {Sid E.} and Guanghua Xiao and Melissa Edwards and Michael Devous and Gupta, {Veer Bala} and Ralph Martins and Fan Zhang and Robert Barber",
year = "2013",
doi = "10.3233/JAD-122074",
language = "English (US)",
volume = "34",
pages = "841--849",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Biomarkers of Alzheimer's disease among Mexican Americans

AU - O'Bryant, Sid E.

AU - Xiao, Guanghua

AU - Edwards, Melissa

AU - Devous, Michael

AU - Gupta, Veer Bala

AU - Martins, Ralph

AU - Zhang, Fan

AU - Barber, Robert

PY - 2013

Y1 - 2013

N2 - Background: Mexican Americans are the fastest aging segment of the U.S. population, yet little scientific literature exists regarding the Alzheimer's disease (AD) among this segment of the population. The extant literature suggests that biomarkers of AD will vary according to race/ethnicity though no prior work has explicitly studied this possibility. The aim of this study was to create a serum-based biomarker profile of AD among Mexican American. Methods: Data were analyzed from 363 Mexican American participants (49 AD and 314 normal controls) enrolled in the Texas Alzheimer's Research & Care Consortium (TARCC). Non-fasting serum samples were analyzed using a luminex-based multi-plex platform. A biomarker profile was generated using random forest analyses. Results: The biomarker profile of AD among Mexican Americans was different from prior work from non-Hispanic populations with regards to the variable importance plots. In fact, many of the top markers were related to metabolic factors (e.g., FABP, GLP-1, CD40, pancreatic polypeptide, insulin-like-growth factor, and insulin). The biomarker profile was a significant classifier of AD status yielding an area under the receiver operating characteristic curve, sensitivity, and specificity of 0.77, 0.92, and 0.64, respectively. Combining biomarkers with clinical variables yielded a better balance of sensitivity and specificity. Conclusion: The biomarker profile for AD among Mexican American cases is significantly different from that previously identified among non-Hispanic cases from many large-scale studies. This is the first study to explicitly examine and provide support for blood-based biomarkers of AD among Mexican Americans. Areas for future research are highlighted.

AB - Background: Mexican Americans are the fastest aging segment of the U.S. population, yet little scientific literature exists regarding the Alzheimer's disease (AD) among this segment of the population. The extant literature suggests that biomarkers of AD will vary according to race/ethnicity though no prior work has explicitly studied this possibility. The aim of this study was to create a serum-based biomarker profile of AD among Mexican American. Methods: Data were analyzed from 363 Mexican American participants (49 AD and 314 normal controls) enrolled in the Texas Alzheimer's Research & Care Consortium (TARCC). Non-fasting serum samples were analyzed using a luminex-based multi-plex platform. A biomarker profile was generated using random forest analyses. Results: The biomarker profile of AD among Mexican Americans was different from prior work from non-Hispanic populations with regards to the variable importance plots. In fact, many of the top markers were related to metabolic factors (e.g., FABP, GLP-1, CD40, pancreatic polypeptide, insulin-like-growth factor, and insulin). The biomarker profile was a significant classifier of AD status yielding an area under the receiver operating characteristic curve, sensitivity, and specificity of 0.77, 0.92, and 0.64, respectively. Combining biomarkers with clinical variables yielded a better balance of sensitivity and specificity. Conclusion: The biomarker profile for AD among Mexican American cases is significantly different from that previously identified among non-Hispanic cases from many large-scale studies. This is the first study to explicitly examine and provide support for blood-based biomarkers of AD among Mexican Americans. Areas for future research are highlighted.

KW - Alzheimer's disease

KW - biomarkers

KW - Mexican American

KW - neuropsychology

UR - http://www.scopus.com/inward/record.url?scp=84876368845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876368845&partnerID=8YFLogxK

U2 - 10.3233/JAD-122074

DO - 10.3233/JAD-122074

M3 - Article

C2 - 23313927

AN - SCOPUS:84876368845

VL - 34

SP - 841

EP - 849

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -